Clinical Trial

Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis

Study acronym: ILLUMINATE
Suspended
View on ClinicalTrials.gov →
Summary
The main purpose of this study is to assess the usability and value of the multiple sclerosis (MS) care management platform in terms of improved monitoring of people with MS (pwMS) in clinical practice. This is a two-year prospective data collection study with additional data collection at baseline evaluating medical practice over a period of at least one year before the introduction of the MS care management platform.
Protocol Amendment History 2 changes
critical Recruitment suspended 2026-07-21
critical Reason stopped changed: — → Transition of study Sponsor. 2026-07-21
Trial Details
NCT Number NCT05949580
Lead Sponsor Hoffmann-La Roche
Collaborators: icometrix
Conditions Relapsing Remitting Multiple Sclerosis
Enrollment 500 participants
Start Date 2024-10-21
Primary Completion 2027-06-30 (estimated)
Study Completion 2028-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-20